NORTHWELL HEALTH

A peer-reviewed narrative review published in Cureus journal highlights the therapeutic potential of long-acting synthetic cannabidiol (CBD) for chronic pain management as a non-opioid alternative.

Feinstein Institutes researchers have discovered how the vagus nerve detects and communicates specific inflammatory signals to the brain, revealing a complex encoding system for immune information.

• Real-world data presented at AUA 2025 shows the CVAC System achieves significant kidney stone volume reduction of up to 99% in most patients, with one study reporting a median clearance rate of 96.4%. • The CVAC System demonstrated superior performance compared to flexible and navigable ureteric access sheath (FANS), removing significantly more absolute stone volume while maintaining consistently low intrarenal pressure. • Multiple studies using Quantitative Stone Analysis Software (QSAS) validate stone volume as a more precise and clinically meaningful measure for assessing kidney stone treatment outcomes.

The FDA is expected to mandate single Institutional Review Board (sIRB) reviews for most multisite clinical research by end of 2024, following similar requirements from NIH and federal research policies.

Leading oncologists at Northwell Health advocate for integrating clinical trials into standard care pathways, emphasizing their role as crucial treatment options rather than last resorts.

Researchers are developing a 'neural tourniquet' that uses vagus nerve stimulation to enhance blood clotting and reduce bleeding during surgery and postpartum.

Weekly tumor boards at Lenox Hill Hospital demonstrate the critical importance of early surgical involvement and multidisciplinary collaboration in treating early-stage lung cancer patients.

Tivic Health's pilot study demonstrated significant physiological responses to their non-invasive cervical vagus nerve stimulation (ncVNS) technology, including a 97% increase in heart rate variability, a key indicator of vagus nerve activity.